Technology Solutions for Late Phase Research

Presented by

Michael Cook, Principal, Epidemiology, ICON Commercialisation & Outcomes

About this talk

With demand increasing for new and innovative approaches to late phase research, technology solutions and access to RWD are at the forefront of creating efficiencies in all stages of study design and implementation. But what steps should you take in study planning to ensure these efficiencies are effectively applied? And how can you partner with CROs to ensure that the secondary and primary data are pulled through the appropriate technology solutions for optimal use? The enrolment process for clinical trials is notoriously inefficient. Sponsors struggle to identify the best investigator sites and enrol the target number of patients amid competing trials. Part of this inefficiency stems from the traditional recruitment model of relying on selected Key Opinion Leaders (KOLs) to recruit patients. With the right information about how many patients are eligible—and where they are located—this model can be turned on its head. EHR data can improve this process dramatically. Our experts will discuss: The use of EHR data to conduct protocol feasibility assessments Efficient site and physician identification, as well as patient identification and enrolment Continued collection of EHR data on enrolled patients for ongoing RWE generation The use of a technology platform to cohesively bring the data together Speakers: Michael Cook, Principal, Epidemiology, ICON; Bill Row, Divisional Principal, RWE, ICON

Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (32)
Subscribers (508)
BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges when it comes to developing their drug or device. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.